Click here for pdf version of this press release

InfuSystem Holdings, Inc. (OTCBB: INHI), the leading provider of ambulatory infusion pump services for administering chemotherapy, today announced the appointment of Scott L. Chesky, CPA, CFA to the position of vice president of strategic development. In this newly created position, Mr. Chesky will spearhead InfuSystem’s business development strategy, focusing on identifying and evaluating acquisition candidates, joint ventures and strategic alliances.

Prior to joining InfuSystem Holdings, Mr. Chesky held the position of vice president within the investment banking group at FTN Midwest Securities Corp. where he primarily focused on mergers and acquisitions for middle market companies in the healthcare and technology sectors. Prior to FTN, Mr. Chesky was with Alterity Partners, a boutique investment bank that was acquired by FTN. During his tenure in investment banking, he has advised a number of notable companies on a broad spectrum of issues, including tender offers, LBOs, asset and stock sales, equity and debt financings, and subsidiary divestitures, among other responsibilities. Mr. Chesky also has previous experience analyzing potential investments for a venture capital firm and as the director of finance for a private foundation. Mr. Chesky began his career at KPMG Peat Marwick where he performed financial statement audits for companies in a variety of industries and was responsible for identifying opportunities for improved efficiencies in financial reporting, internal controls and business operations. Mr. Chesky has an M.B.A. from Columbia Business School and a Bachelor of Science in accounting from Bucknell University in Pennsylvania.

Steve Watkins, chief executive officer of InfuSytem Holdings, stated, “Scott brings a wealth of financial and strategic experience to InfuSystem. His expertise in identifying and evaluating acquisition candidates, especially those in the healthcare sector, make him a very valuable addition to our team as we supplement organic growth opportunities with strategic acquisitions, joint ventures and strategic alliances. As an investment banker, Scott has been involved with companies in many different areas of healthcare, including medical devices, coding and billing, disease management, distribution, medical education and pharmaceutical services. Moreover, his extensive involvement, while at FTN, with InfuSystem and our management team during the time leading up to the divestiture of the company from I-Flow Corporation has been invaluable and we look forward to his continued contributions to the company.”

About InfuSystem

InfuSystem provides external ambulatory infusion pump services to doctors and their patients allowing for the gradual delivery of a drug over a period of days in the privacy of one’s home, rather than higher dose treatments, as is the case of chemotherapy administered in a hospital setting or doctor’s office.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks detailed from time to time in InfuSystem’s publicly filed documents.

###